【今日科学 郭川】近年来，国际期刊发现伪造审稿人邮箱的案例近300起。近日，中国五篇医学类论文因同样的原因被撤销。作者通过伪造审稿人邮箱，是自己变身“审稿人”，为自己的论文开绿灯助其发表。
期刊在对五篇论出的撤销声明中指出，伪造审稿人邮箱严重违反同行评议、出版政策和出版道德标准的底线。
据了解，五篇论文分别来自中国著名高校或其附属医院，包括中国医科大学附属盛京医院、重庆医科大学、浙江大学医学院第一附属医院、复旦大学华山医院等单位。
五篇被撤销的论文如下：
1. The synergistic effect between beta-amyloid(1-42) and alpha-synuclein on the synapses dysfunction in hippocampal neurons, published in the Journal of Chemical Neuroanatomy and cited three times
2. Predictive and prognostic value of ER-α36 expression in breast cancer patients treated with chemotherapy, published in Steroids and cited seven times
3. Protein–protein interaction and SNP ysis in intraductal papillary mucinous neopla, published in Gene and cited four times
4. Microarray ysis of microRNA expression in liver cancer tissues and normal control, also published in Gene and cited 11 times
5. Candidate agents for pancreatic ductal adenocarcinoma identified by a sub-pathway based method, also published in Gene, and cited once
中国医学类论文一段时间以来频现学术不端现象，广受诟病。去年，德国施普林格出版集团于8月18日撤回旗下10本学术周刊上发表的64篇论文，原因是同行评议过程造假。大多数涉事论文的作者来自中国的医学类论文。
